Pharma Mar SA

ISIN ES0169501022

 | 

Code du titre A2P9YT

Cap. boursière (en EUR)
1,776 m
Country
Spain
Secteur
Healthcare
Rendement en dividendes
0.81%
 

Aperçu

Description

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.
Afficher plus Afficher moins
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals Spain

Données financières

Indicateurs clés

Capitalisation boursière, EUR 1,776 m
BPA, EUR 4.29
Ratio cours/valeur comptable 6.8
PER 22.9
Rendement en dividendes 0.81%

Income statement (2025)

Chiffre d'affaires, EUR 221 m
Résultat net, EUR 75 m
Marge bénéficiaire 33.87%

What ETF is Pharma Mar SA in?

There are 4 ETFs which contain Pharma Mar SA. All of these ETFs are listed in the table below. The ETF with the largest weighting of Pharma Mar SA is the Xtrackers Spanish Equity UCITS ETF 1D.
ETF Weight Investment focus Fund size (in m EUR)
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing 0.01%
Equity
Europe
Social/Environmental
34
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
506
Xtrackers Spanish Equity UCITS ETF 1D 0.15%
Equity
Spain
261
Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist 0.09%
Equity
Europe
Small Cap
Climate Change
394
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.